“Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients With Major Depressive Disorder”. 2022. Precision Medicine Communications 2 (1): 27-42. https://doi.org/10.55627/pmc.002.01.0044.